Back to Search
ADAM GIERMASZ, M.D., PHD
M.D., PHD
Hematology & Oncology Physician
NPI: 1831374644IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
A103790(CA)
Education
OTHER
Class of 1998
Research & Publications (17)
Type-1 polarized dendritic cells primed for high IL-12 production show enhanced activity as cancer vaccines.
PMID 19156413·Cancer Immunol Immunother·2009
7-preclinical
Potentiating antitumor effects of a combination therapy with lovastatin and butyrate in the Lewis lung carcinoma model in mice.
PMID 11857349·Int J Cancer·2002
7-preclinical
Antitumor activity of tributyrin in murine melanoma model.
PMID 11179828·Cancer Lett·2001
7-preclinical
Helper function of memory CD8+ T cells: heterologous CD8+ T cells support the induction of therapeutic cancer immunity.
PMID 17942935·Cancer Res·2007
7-preclinical
Helper roles of NK and CD8+ T cells in the induction of tumor immunity. Polarized dendritic cells as cancer vaccines.
PMID 17337774·Immunol Res·2006
6-review
Natural killer-dendritic cell cross-talk in cancer immunotherapy.
PMID 16197336·Expert Opin Biol Ther·2005
6-review
Helper role of NK cells during the induction of anticancer responses by dendritic cells.
PMID 15607810·Mol Immunol·2005
6-review
Increased local vascular endothelial growth factor expression associated with antitumor activity of proteasome inhibitor.
PMID 15004516·Apoptosis·2004
7-preclinical
Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function.
PMID 12928383·J Immunol·2003
8-other
Type-1 polarized nature of mouse liver CD8alpha- and CD8alpha+ dendritic cells: tissue-dependent differences offset CD8alpha-related dendritic cell heterogeneity.
PMID 12884867·Eur J Immunol·2003
7-preclinical
Augmented antitumour effects of combination therapy with TNP-470 and chemoimmunotherapy in mice.
PMID 12200600·J Cancer Res Clin Oncol·2002
7-preclinical
Potentiated antitumor effects of interleukin 12 and interferon alpha against B16F10 melanoma in mice.
PMID 11845979·Neoplasma·2001
7-preclinical
Potentiatied antitumor effectiveness of combined chemo-immunotherapy with interleukin-12 and 5-fluorouracil of L1210 leukemia in vivo.
PMID 11368364·Leukemia·2001
7-preclinical
Lovastatin and simvastatin are modulators of the proteasome.
PMID 11084375·Int J Biochem Cell Biol·2000
7-preclinical
Lovastatin potentiates antitumor activity and attenuates cardiotoxicity of doxorubicin in three tumor models in mice.
PMID 10815931·Clin Cancer Res·2000
7-preclinical
Potentiation of the anti-tumour effects of Photofrin-based photodynamic therapy by localized treatment with G-CSF.
PMID 10780531·Br J Cancer·2000
7-preclinical
Interleukin 12 and indomethacin exert a synergistic, angiogenesis-dependent antitumor activity in mice.
PMID 10737417·Life Sci·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2000 STOCKTON BLVD, SUITE 202
SACRAMENTO, CA 95817 - Phone
- (916) 734-3461
Quick Facts
- NPI
- 1831374644
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 28
- Publications
- 17
Are you this provider?
Claim Your Profile